Skip to content
Screener

aTyr Pharma ATYR Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$10.31M+47.2%-$10.79M+27.5%-$13.96M+6.7%-$25.75M-49.2%-$19.53M-19.8%
$168K+1.2%$162K-3.0%$166K-5.1%$165K-7.3%$166K-6.2%
$1.15M-12.3%$1.31M+11.0%$1.21M+56.8%$1.31M+73.8%$1.31M+79.5%
-$9.35M+32.7%-$12.52M+18.8%-$12.2M+7.1%-$20.48M-55.6%-$13.89M+32.1%
$73K+711%$138K$31K+24.0%$37K+147%$9K+12.5%
$15.32M$11.49M+360%-$20.38M-214%
-$129K-101%-$142K-101%$0-100%$29.62M$17.9M+33.6%
$5.84M-20.0%-$1.17M+3.9%-$11.24M$7.3M+2,375%
-$9.42M+32.2%-$12.66M+17.9%-$12.23M+7.1%-$20.51M-55.7%-$13.9M+32.0%

FAQ

How much cash does aTyr Pharma generate?
aTyr Pharma (ATYR) generated -$54.5M in operating cash flow over the trailing twelve months.
What is aTyr Pharma's free cash flow?
After $279.0K of capital expenditures, aTyr Pharma's free cash flow was -$54.8M over the trailing twelve months, up 1.5% year over year.
Where does aTyr Pharma's cash flow data come from?
Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.